vs
Esperion Therapeutics, Inc.（ESPR）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是Esperion Therapeutics, Inc.的1.3倍（$225.0M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 24.9%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -12.3%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
ESPR vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.3倍
$168.4M
营收增速更快
ESPR
高出118.8%
24.9%
两年增速更快
ESPR
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $225.0M |
| 净利润 | — | — |
| 毛利率 | — | 25.3% |
| 营业利润率 | 50.6% | 7.9% |
| 净利率 | — | — |
| 营收同比 | 143.7% | 24.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRROCK
| Q4 25 | $168.4M | $225.0M | ||
| Q3 25 | $87.3M | $310.9M | ||
| Q2 25 | $82.4M | $309.5M | ||
| Q1 25 | $65.0M | $290.0M | ||
| Q4 24 | $69.1M | $180.1M | ||
| Q3 24 | $51.6M | $277.1M | ||
| Q2 24 | $73.8M | $273.6M | ||
| Q1 24 | $137.7M | $292.5M |
净利润ESPRROCK
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-89.1M | ||
| Q2 25 | $-12.7M | $26.0M | ||
| Q1 25 | $-40.5M | $21.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $34.0M | ||
| Q2 24 | $-61.9M | $32.2M | ||
| Q1 24 | $61.0M | $24.9M |
毛利率ESPRROCK
| Q4 25 | — | 25.3% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 28.9% |
营业利润率ESPRROCK
| Q4 25 | 50.6% | 7.9% | ||
| Q3 25 | -11.4% | 12.8% | ||
| Q2 25 | 8.6% | 12.8% | ||
| Q1 25 | -34.0% | 8.8% | ||
| Q4 24 | -6.4% | 13.3% | ||
| Q3 24 | -31.0% | 15.6% | ||
| Q2 24 | 3.5% | 14.9% | ||
| Q1 24 | 52.5% | 10.8% |
净利率ESPRROCK
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -28.6% | ||
| Q2 25 | -15.4% | 8.4% | ||
| Q1 25 | -62.2% | 7.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | 12.3% | ||
| Q2 24 | -83.9% | 11.8% | ||
| Q1 24 | 44.3% | 8.5% |
每股收益（稀释后）ESPRROCK
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $-2.98 | ||
| Q2 25 | $-0.06 | $0.87 | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | $1.11 | ||
| Q2 24 | $-0.33 | $1.05 | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $-302.0M | $950.4M |
| 总资产 | $465.9M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ESPRROCK
| Q4 25 | $167.9M | $115.7M | ||
| Q3 25 | $92.4M | $89.4M | ||
| Q2 25 | $86.1M | $43.3M | ||
| Q1 25 | $114.6M | $25.1M | ||
| Q4 24 | $144.8M | $269.5M | ||
| Q3 24 | $144.7M | $228.9M | ||
| Q2 24 | $189.3M | $179.1M | ||
| Q1 24 | $226.6M | $146.7M |
总债务ESPRROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益ESPRROCK
| Q4 25 | $-302.0M | $950.4M | ||
| Q3 25 | $-451.4M | $951.8M | ||
| Q2 25 | $-433.5M | $1.0B | ||
| Q1 25 | $-426.2M | $1.0B | ||
| Q4 24 | $-388.7M | $1.0B | ||
| Q3 24 | $-370.2M | $1.0B | ||
| Q2 24 | $-344.2M | $975.7M | ||
| Q1 24 | $-294.3M | $940.2M |
总资产ESPRROCK
| Q4 25 | $465.9M | $1.4B | ||
| Q3 25 | $364.0M | $1.4B | ||
| Q2 25 | $347.1M | $1.5B | ||
| Q1 25 | $324.0M | $1.4B | ||
| Q4 24 | $343.8M | $1.4B | ||
| Q3 24 | $314.1M | $1.4B | ||
| Q2 24 | $352.3M | $1.4B | ||
| Q1 24 | $373.1M | $1.3B |
负债/权益比ESPRROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | — | $26.2M |
| 自由现金流率自由现金流/营收 | — | 11.7% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $120.6M |
8季度趋势，按日历期对齐
经营现金流ESPRROCK
| Q4 25 | $45.2M | $35.5M | ||
| Q3 25 | $-4.3M | $73.0M | ||
| Q2 25 | $-31.4M | $44.9M | ||
| Q1 25 | $-22.6M | $13.7M | ||
| Q4 24 | $-35.0M | $19.9M | ||
| Q3 24 | $-35.3M | $64.7M | ||
| Q2 24 | $-7.2M | $36.5M | ||
| Q1 24 | $53.8M | $53.2M |
自由现金流ESPRROCK
| Q4 25 | — | $26.2M | ||
| Q3 25 | — | $64.8M | ||
| Q2 25 | — | $27.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $-35.5M | $60.5M | ||
| Q2 24 | $-7.3M | $33.5M | ||
| Q1 24 | $53.8M | $48.8M |
自由现金流率ESPRROCK
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 20.8% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -68.7% | 21.8% | ||
| Q2 24 | -9.9% | 12.2% | ||
| Q1 24 | 39.0% | 16.7% |
资本支出强度ESPRROCK
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 5.7% | ||
| Q1 25 | 0.0% | 3.9% | ||
| Q4 24 | 0.0% | 3.3% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | 0.1% | 1.5% |
现金转化率ESPRROCK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.73× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | 0.88× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
